Atlas Trials

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Clinical trial NCT02285920 · COMPLETED

Trial details

NCT number
NCT02285920
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
End-Stage Renal Disease
Start date
2014-11-01
Primary completion
2017-06-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.